Tazemetostat
Tazemetostat
Tazemetostat (pronounced ta-zuh-ME-toh-stat) is a medication used in the treatment of certain types of cancer. It is an enzyme inhibitor that works by blocking the activity of a specific enzyme known as EZH2.
Etymology
The name "Tazemetostat" is derived from the drug's chemical structure and its mechanism of action. The prefix "Taz" is an abbreviation of the chemical name, while "metostat" refers to the drug's ability to inhibit the EZH2 enzyme.
Usage
Tazemetostat is used in the treatment of Epithelioid Sarcoma, a rare type of soft tissue sarcoma, and certain types of Non-Hodgkin Lymphoma. It is usually given after other treatments have failed.
Side Effects
Common side effects of Tazemetostat include fatigue, nausea, vomiting, constipation, and decreased appetite. More serious side effects can include lung problems, serious infections, and an increased risk of secondary malignancies.
Related Terms
- EZH2: The enzyme that Tazemetostat inhibits.
- Epithelioid Sarcoma: A type of cancer that Tazemetostat is used to treat.
- Non-Hodgkin Lymphoma: Another type of cancer that Tazemetostat is used to treat.
- Enzyme Inhibitor: A type of drug that works by blocking the activity of a specific enzyme.
External links
- Medical encyclopedia article on Tazemetostat
- Wikipedia's article - Tazemetostat
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski